Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients
Clinical trial NCT07493980 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07493980
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-01-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.